Open-label Phase II Study of Induction Treatment With Folfoxiri Plus Bevacizumab Followed by Preoperative Chemoradiotherapy Plus Bevacizumab in Patients With Locally Advanced, Resectable Rectal Cancer.
Phase of Trial: Phase II
Latest Information Update: 24 Mar 2017
At a glance
- Drugs Bevacizumab (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Rectal cancer
- Focus Therapeutic Use
- Acronyms TRUST
- 11 Oct 2016 Results presented at the 41st European Society for Medical Oncology Congress
- 11 Oct 2016 After the first 13 pts, the protocol was amended and the schedule of capecitabine slightly modified (800 mg/m2/bid 5 days/week).
- 03 Sep 2012 New trial record